MedPath

Psychological predictors and consequences of nocturnal hypo- and hyperglycemia in adults with type 1 diabetes and their main relative: the DiaN8 study

Recruiting
Conditions
Type 1 diabetes
insulin-dependent diabetes
10018424
Registration Number
NL-OMON54723
Lead Sponsor
Radboud Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

In order to be eligible to participate in this study, a person must meet all of
the following criteria:
- a diagnosis of type 1 diabetes based on the medical record;
- age between 16-64 years;
- diabetes duration >=1 year.
The main relative may participate as well, provided:
- the person with diabetes consents to their participation;
- for a parent: the person with diabetes is living at the parent*s home;
- for a partner: the person with diabetes and the partner are living together.

Exclusion Criteria

A potential participant who meets any of the following criteria will be
excluded from participation in this study:
- inability to speak and read the Dutch language;
- advanced complications (low vision, blindness, kidney disease as evidenced by
Modification of Diet in Renal Disease score <45 or macroalbuminuria,
symptomatic autonomic neuropathy, amputations, stroke, myocardial infarction or
peripheral arterial disease in the previous year or with moderate to severe
residual symptom severity);
- other somatic or psychiatric comorbidities or psychosocial problems
interfering with the ability to provide informed consent or with study
participation;
- pregnancy, breast feeding;
- moderate to severe menopausal symptom severity.

Reasons for postponing participation include:
- recent or planned shift work or time zone travel.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameters are the presence of health beliefs and emotions<br /><br>related to nocturnal hypo- and hyperglycemia; behavior with likely hypoglycemic<br /><br>or hyperglycemic impact during the night; nocturnal hypo- and hyperglycemic<br /><br>events; sleep quality; and daytime mood, fatigue, and cognitive functioning.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Changes in glucose levels, sleep quality, mood, fatigue, and cognitive<br /><br>functioning from the first ambulatory assessment to an optional second<br /><br>ambulatory assessment three months later.</p><br>
© Copyright 2025. All Rights Reserved by MedPath